Literature DB >> 11261791

Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.

B H Rovin1, L Lu, C B Marsh.   

Abstract

Leukocyte recruitment to the kidney in immune complex disease like systemic lupus erythematosus (SLE) is mediated in part by local expression of chemokines such as monocyte chemoattractant protein-1 (MCP-1). Recent studies from this laboratory demonstrated that cross-linking Fc gammaR on lymphocytes causes release of a soluble factor that induces monocyte chemokine production. To explain the induction of renal chemokine expression in immune complex disease, we postulated that this lymphocyte factor stimulates renal parenchymal cell MCP-1 expression. To test this hypothesis, human peripheral blood lymphocytes were incubated on immobilized IgG, a model for immune complex Fc gammaR cross-linking. Supernatants from these lymphocyte cultures significantly increased MCP-1 production by human mesangial, glomerular capillary endothelial, and proximal tubular epithelial cells. Mesangial cells incubated on immobilized IgG or with soluble, preformed immune complexes did not secrete MCP-1 above control levels. Lymphocyte supernatant-induced MCP-1 production appeared to be dependent on the presence of interleukin (IL)-1beta in the supernatant. Removing IL-1beta from the supernatants, antagonizing its activity, or preventing conversion to mature IL-1beta abrogated renal cell MCP-1 expression by the lymphocyte supernatants. These data demonstrate that in response to cross-linking Fc gammaR, lymphocytes induce renal cell MCP-1 expression by secreting IL-1beta. Renal chemokine expression in immune complex disease may thus be triggered as lymphocytes traffic through the kidney and encounter deposited immune complexes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11261791

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Conference report--lupus nephritis: diagnosis, therapy, and outcomes.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-07-02

2.  Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.

Authors:  María Colmenares; Stephanie L Constant; Peter E Kima; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis.

Authors:  Jennifer R Timoshanko; A Richard Kitching; Yichiro Iwakura; Stephen R Holdsworth; Peter G Tipping
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 4.  Of mice and men: the relevance of the mouse to the study of human SLE.

Authors:  D J Birmingham; B H Rovin; C Y Yu; L A Hebert
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

Review 5.  Chemokines and Chemokine Receptors in the Development of Lupus Nephritis.

Authors:  Xiaofeng Liao; Tharshikha Pirapakaran; Xin M Luo
Journal:  Mediators Inflamm       Date:  2016-06-14       Impact factor: 4.711

6.  ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice.

Authors:  José Bruno N F Silva; Thayanne B B Calcia; Cyntia P Silva; Rafael F Guilherme; Fernando Almeida-Souza; Felipe S Lemos; Kátia S Calabrese; Celso Caruso-Neves; Josiane S Neves; Claudia F Benjamim
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.